Of participants with elevated baseline ALT levels, 53.8% vs 33.3% had normal levels at week 68 with semaglutide vs placebo, respectively
Real-world use of oral semaglutide in adults with type 2 diabetes: the PIONEER REAL Switzerland multicentre, prospective, observational study
For many, the battle against weight is as much mental as it is physical
N., Wharton, S., Connery, L., Alves, B., & Garvey, W
In clinical trials, GI side effects occur in roughly 4050% of patients on either medication, though they are typically mild to moderate and tend to improve over the first 812 weeks
Temporarily, yes